Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice

International Journal of Neuropsychopharmacology

Volumn 12, Issue 2, 2009, Pages 243-255

  Beraki, Simret ^a   Diaz Heijtz, Rochellys ^a   Tai, Fadao ^a   Ögren, Sven Ove ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arc; Cognitive function; Mice; Phencyclidine; Schizophrenia; Spinophilin

Indexed keywords

MESSENGER RNA; PHENCYCLIDINE; SODIUM CHLORIDE; SPINOPHILIN; WATER; ACTIN BINDING PROTEIN; ACTIVITY REGULATED CYTOSKELETAL-ASSOCIATED PROTEIN; ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; CYTOSKELETON PROTEIN; NERVE PROTEIN; NEURABIN; PSYCHEDELIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARC GENE; ARTICLE; BEHAVIOR; BRAIN CORTEX; BRAIN REGION; C57BL 6 MOUSE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; DRUG MECHANISM; GENE; GENE EXPRESSION; HIPPOCAMPUS; LEARNING; LEARNING DISORDER; LOW DRUG DOSE; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RETROSPLENIAL AGRANULAR CORTEX; SCHIZOPHRENIA; SPINOPHILIN GENE; THERAPY EFFECT; WORKING MEMORY; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METHODOLOGY; MOTOR ACTIVITY; ROTAROD TEST; SHORT TERM MEMORY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COGNITION; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HALLUCINOGENS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PHENCYCLIDINE; ROTAROD PERFORMANCE TEST; SPATIAL BEHAVIOR;

EID: 67049136754     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145708009152     Document Type: Article

References (61)

1. Adams B, Moghaddam B (1998). Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. Journal of Neuroscience 18, 5545-5554.
2. Ahlander M, Misane I, Schott PA, Ogren SO (1999). A behavioral analysis of the spatial learning deficit induced by the NMDA receptor antagonist MK-801 (dizocilpine) in the rat. Neuropsychopharmacology 21, 414-426.
3. Andreasen NC (1996). Pieces of the schizophrenia puzzle fall into place. Neuron 16, 697-700.
4. Bakshi VP, Swerdlow NR, Geyer MA (1994). Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. Journal of Pharmacology and Experimental Therapeutics 271, 787-794.
5. Beraki S, Aronsson F, Karlsson H, Ogren SO, Kristensson K (2005). Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Molecular Psychiatry 10, 299-308.
6. Beraki S, Kuzmin A, Tai F, Ogren SO (2008). Repeated low dose of phencyclidine administration impairs spatial learning in mice: Blockade by clozapine but not by haloperidol. European Neuropsychopharmacology 18, 486-497.
7. Boyer P, Phillips JL, Rousseau FL, Ilivitsky S (2007). Hippocampal abnormalities and memory deficits: new evidence of a strong pathophysiological link in schizophrenia. Brain Research Reviews 54, 92-112.
8. Burwell RD, Saddoris MP, Bucci DJ, Wiig KA (2004). Corticohippocampal contributions to spatial and contextual learning. Journal of Neuroscience 24, 3826-3836.
9. Cain DP, Saucier D, Hall J, Hargreaves EL, Boon F (1996). Detailed behavioral analysis of water maze acquisition under APV or CNQX: contribution of sensorimotor disturbances to drug-induced acquisition deficits. Behavioral Neuroscience 110, 86-102. (Pubitemid 26068798)
10. Carlsson A, Lindqvist M (1963). Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacologica et Toxicologica (Copenhagen) 20, 140-144.
11. Castellani S, Adams PM (1981). Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. European Journal of Pharmacology 73, 143-154.
12. Clinton SM, Ibrahim HM, Frey KA, Davis KL, Haroutunian V, Meador-Woodruff JH (2005). Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. American Journal of Psychiatry 162, 1859-1871.
13. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW (1995). Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology (Berlin) 120, 67-74.
14. Daberkow DP, Riedy MD, Kesner RP, Keefe KA (2007). Arc mRNA induction in striatal efferent neurons associated with response learning. European Journal of Neuroscience 26, 228-241.
15. Ellison G, Switzer RC (1993). Dissimilar patterns of degeneration in brain following four different addictive stimulants. Neuroreport 5, 17-20.
16. Feng J, Yan Z, Ferreira A, Tomizawa K, Liauw JA, Zhuo M, Allen PB, Ouimet CC, Greengard P (2000). Spinophilin regulates the formation and function of dendritic spines. Proceedings of the National Academy of Sciences USA 97, 9287-9292.
17. Fosnaugh JS, Bhat RV, Yamagata K, Worley PF, Baraban JM (1995). Activation of arc, a putative 'effector' immediate early gene, by cocaine in rat brain. Journal of Neurochemistry 64, 2377-2380.
18. Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA (2000). Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. Journal of Neuroscience 20, 3993-4001.
19. Guzowski JF, McNaughton BL, Barnes CA, Worley PF (1999). Environment-specific expression of the immediate-early gene Arc in hippocampal neuronal ensembles. Nature Neuroscience 2, 1120-1124.
20. Hashimoto K, Fujita Y, Shimizu E, Iyo M (2005). Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol. European Journal of Pharmacology 519, 114-117.
21. Jackson DM, Johansson C, Lindgren LM, Bengtsson A (1994). Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacology Biochemistry & Behavior 48, 465-471.
22. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 148, 1301-1308.
23. Jentsch JD, Roth RH (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
24. Keene CS, Bucci DJ (2008). Contributions of the retrosplenial and posterior parietal cortices to cue-specific and contextual fear conditioning. Behavioral Neuroscience 122, 89-97.
25. Kesner RP, Dakis M (1997). Intrahippocampal injections of phencyclidine but not naloxone disrupt acquisition of a spatial continuous recognition memory task. Pharmacology Biochemistry & Behavior 56, 97-101.
26. Kesner RP, Dakis M, Bolland BL (1993). Phencyclidine disrupts long- but not short-term memory within a spatial learning task. Psychopharmacology (Berlin) 111, 85-90.
27. Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T (1994). Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Japanese Journal of Pharmacology 66, 181-189.
28. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers Jr. MB, Charney DS (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 51, 199-214.
29. Law AJ, Weickert CS, Hyde TM, Kleinman JE, Harrison PJ (2004). Reduced spinophilin but not microtubule-associated protein 2 expression in the hippocampal formation in schizophrenia and mood disorders: molecular evidence for a pathology of dendritic spines. American Journal of Psychiatry 161, 1848-1855.
30. Li Z, Kim CH, Ichikawa J, Meltzer HY (2003). Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice. Pharmacology Biochemistry & Behavior 75, 335-340.
31. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959). Study of a new schizophrenomimetic drug; sernyl. Archives of Neurology and Psychiatry 81, 363-369.
32. Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, Gilbert DJ, Jenkins NA, Lanahan AA, Worley PF (1995). Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433-445.
33. Malhotra AK, Adler CM, Kennison SD, Elman I, Pickar D, Breier A (1997). Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine. Biological Psychiatry 42, 664-668.
34. Mandillo S, Rinaldi A, Oliverio A, Mele A (2003). Repeated administration of phencyclidine, amphetamine and MK-801 selectively impairs spatial learning in mice: a possible model of psychotomimetic drug-induced cognitive deficits. Behavioural Pharmacology 14, 533-544.
35. Meltzer HY, McGurk SR (1999). The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 25, 233-255.
36. Morris BJ, Cochran SM, Pratt JA (2005). PCP: from pharmacology to modelling schizophrenia. Current Opinion in Pharmacology 5, 101-106.
37. Morris RG, Frey U (1997). Hippocampal synaptic plasticity: role in spatial learning or the automatic recording of attended experience? Philosophical Transactions of the Royal Society of London. B: Biological Sciences 352, 1489-1503.
38. Nakahara T,Kuroki T,Hashimoto K, Hondo H, Tsutsumi T, Motomura K, Ueki H, Hirano M, Uchimura H (2000). Effect of atypical antipsychotics on phencyclidine-induced expression of arc in rat brain. Neuroreport 11, 551-555.
39. Ogren SO, Goldstein M (1994). Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11, 167-177.
40. Olney JW, Labruyere J, Price MT (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244, 1360-1362.
41. Olney JW, Newcomer JW, Farber NB (1999). NMDA receptor hypofunction model of schizophrenia. Journal of Psychiatric Research 33, 523-533.
42. Park S, Holzman PS (1992). Schizophrenics show spatial working memory deficits. Archives of General Psychiatry 49, 975-982.
43. Paxinos G, Franklin K (2001). The Mouse Brain in Stereotaxic Coordinates. New York, NY: Academic Press.
44. Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C, Mao X, Engelsberg A, Mahlke C, Welzl H, et al. (2006). Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories. Neuron 52, 437-444.
45. Podhorna J, Didriksen M (2005). Performance of male C57BL/6J mice and Wistar rats in the water maze following various schedules of phencyclidine treatment. Behavioural Pharmacology 16, 25-34.
46. Proksch JW, Gentry WB, Owens SM (2000). The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum. Drug Metabolism and Disposition 28, 742-747.
47. Samaha AN, Mallet N, Ferguson SM, Gonon F, Robinson TE (2004). The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. Journal of Neuroscience 24, 6362-6370.
48. Sams-Dodd F (1998a). Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats. Neuropsychopharmacology 19, 18-25.
49. Sams-Dodd F (1998b). Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Psychopharmacology (Berlin) 135, 182-193. (Pubitemid 28055502)
50. Sams-Dodd F (1999). Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Reviews in the Neurosciences 10, 59-90.
51. Sarrouilhe D, di Tommaso A, Metaye T, Ladeveze V (2006). Spinophilin: from partners to functions. Biochimie 88, 1099-1113.
52. Sawa A, Snyder SH (2002). Schizophrenia: diverse approaches to a complex disease. Science 296, 692-695.
53. Scoville WB, Milner B (2000). Loss of recent memory after bilateral hippocampal lesions. 1957. Journal of Neuropsychiatry and Clinical Neuroscience 12, 103-113.
54. Squire LR, Zola-Morgan S (1991). The medial temporal lobe memory system. Science 253, 1380-1386.
55. Stefani MR, Moghaddam B (2002). Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behavioural Brain Research 134, 267-274.
56. Steward O, Wallace CS, Lyford GL, Worley PF (1998). Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated postsynaptic sites on dendrites. Neuron 21, 741-751.
57. Steward O, Worley PF (2001). Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation. Neuron 30, 227-240.
58. Sturgeon RD, Fessler RG, London SF, Meltzer HY (1982). Behavioral effects of chronic phencyclidine administration in rats. Psychopharmacology (Berlin) 76, 52-56.
59. Tzingounis AV, Nicoll RA (2006). Arc/Arg3.1: linking gene expression to synaptic plasticity and memory. Neuron 52, 403-407.
60. Varty GB, Bakshi VP, Geyer MA (1999). M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20, 311-321.
61. Wu LJ, Ren M, Wang H, Kim SS, Cao X, Zhuo M (2008). Neurabin contributes to hippocampal long-term potentiation and contextual fear memory. PLoS ONE 3, e1407.